微信式延续护理在防治乳腺癌患者化疗后骨髓抑制不良反应中的应用

Application of continuous nursing by Wechat to prevent myelosuppression in breast cancer patients that after the adjuvant chemotherapy

目的:评价基于微信的延续性护理在防治乳腺癌患者化疗后骨髓抑制不良反应中的应用效果。方法:将96例术后接受辅助化疗的乳腺癌患者随机分为试验组和对照组各48例。试验组以基于微信的延续性护理进行化疗后骨髓抑制不良反应防治指导,对照组按常规方法给予化疗后骨髓抑制不良反应防治指导。比较两组患者化疗后骨髓抑制不良反应发生率以及防治指导满意率。结果:试验组患者Ⅰ~Ⅳ级的骨髓抑制不良反应与对照组相比无统计学差异(P>0.05),但是Ⅲ级以上的白细胞和中性粒细胞减低的发生率试验组患者则明显低于对照组(P<0.05);试验组患者满意度明显高于对照组(P<0.05)。结论:基于微信的延续性护理,运用于乳腺癌患者辅助化疗期间骨髓抑制不良反应防治指导可降低Ⅲ级以上严重白细胞/中性粒细胞不良反应的发生率,提高患者的满意度。

Objective To study the effect of continuous nursing by Wechat in myelosuppression prevention for breast cancer patients that after the adjuvant chemotherapy. Methods A total of 96 breast cancer patients receiving radical mastectomy were divided equally into experimental group and control group. The patients in the experimental group received continuing care based on Wechat in myelosuppression prevention guidance during the period of adjuvant chemotherapy, while patients in the control group were given routine discharge guidance. The incidence rates of myelosuppression was compared as well as the satisfaction rate about the prevention guidance between the experimental group and the control group. Results There were no obvious differences in the incident rate of Grade Ⅰ-Ⅳ myelosuppression between the experimental group and the control group （P〉0.05）. However, the incident rate of Grade Ⅲ -Ⅳ leukopenia/neutropenia in the experimental group was obviously lower than that of the control group （P〈0.05）. Besides, patient satisfaction rate in the experimental group was obviously higher than that of control group （P〈0.05）. Conclusion The way of guiding myelosuppression prevention for breast cancer patients during the period of adjuvant chemotherapy through continuing care based on Wechat can reduce the incidence rate of serious leukopenia/neutropenia and improve patients＇ satisfaction.